镰状细胞贫血缺氧状态下HIF-1α和VEGF基因表达:羟基脲治疗的影响
本研究探讨镰状细胞贫血(SCA)患者缺氧反应基因表达及其与临床实验室特征和羟基脲治疗的相关性。结果显示,SCA患者HIF-1α和VEGF基因表达显著升高,且与羟基脲治疗呈反向剂量反应关系,提示缺氧应激可能参与SCA严重程度及治疗反应。
要点
- SCA患者HIF-1α和VEGF基因表达显著升高。
- HIF-1α和VEGF表达与羟基脲治疗呈反向剂量反应关系。
- 缺氧应激可能参与SCA严重程度和治疗反应。
核心结论
- SCA患者HIF-1α和VEGF基因表达显著升高,且与羟基脲治疗呈反向剂量反应关系,提示缺氧应激可能参与SCA严重程度及治疗反应。
研究设计与样本
- 研究检测SCA患者缺氧反应基因表达,并分析其与临床实验室特征及羟基脲治疗的相关性。
主要发现
- 首次发现SCA患者HIF-1α和VEGF基因表达显著升高。
- HIF-1α和VEGF表达与羟基脲治疗呈反向剂量反应关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypoxia and hemoglobin S polymerization are two triggers responsible for initiating erythrocyte sickling and the consequent clinical sickle cell anemia (SCA) events. The objective of this study was to investigate the expression of hypoxia-responsive genes in SCA, testing for correlation with the clinical-laboratorial characteristics of the patient and hydroxyurea therapy. Our results showed, for the first time, a significantly increased expression of HIF-1α and VEGF genes in patients with SCA and an inverse dose-response relationship with hydroxyurea therapy. These results suggest that hypoxic stress may be involved in both the severity of SCA and its response to treatment.
引用
- Pedrosa AM, Lemes RPG. Gene expression of HIF-1α and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide. Br J Haematol. 2020. PMID: 32352161. doi:10.1111/bjh.16693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。